Blood-Based MRD Testing -EasyM | Abir Khaled, PhD | #IMS2025

Imagine checking your myeloma minimal residual disease (MRD) with a simple blood test—no bone marrow biopsy needed. That’s the goal of EasyM, a new non-invasive, blood-based MRD test being studied in multiple myeloma.

In this video, we explain:

What MRD (minimal residual disease) means and why it matters

How EasyM works to detect tiny amounts of myeloma in the blood

How this test could one day replace bone marrow biopsies

What current research shows about its accuracy and potential

This innovation could make myeloma monitoring easier, more comfortable, and more frequent for patients in the future.

Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!

Patients have the key to find cures for cancer. Learn more about HealthTree Cure Hub here: https://healthtree.org/curehub?utm_source=social+media&utm_medium=htu+youtube&utm_campaign=htu-curehub&utm_content=general

Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.

Видео Blood-Based MRD Testing -EasyM | Abir Khaled, PhD | #IMS2025 канала HealthTree Foundation for Multiple Myeloma